Reply to Wolowich and Kwon

Clin Infect Dis. 2021 May 4;72(9):1678-1680. doi: 10.1093/cid/ciaa911.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents
  • COVID-19 Drug Treatment*
  • Humans
  • Hydroxychloroquine
  • SARS-CoV-2*

Substances

  • Antiviral Agents
  • Hydroxychloroquine